Get a fresh start.
Add this topic to your myFT Digest for news straight to your inbox
Market forecast to reach £16.5bn in the next decade
Co-chief executive to stand down as board seeks leader for ‘next phase of growth’
State advisory body says monopoly would raise as much as €2.8bn in tax receipts
Recreational cannabis draws more than double the investments in medical
£12.6bn investment portfolios to remove across-the-board ban on marijuana
Strict laws mean that drink and tobacco companies are staying clear of nascent sector
Drinks group eyes new routes to growth as US-Japanese integration woes ease
New Play Store policy in line with restrictions on alcohol and tobacco
Ivan Menezes focuses on spirits as drinks group sets out new financial targets
An asset-management slant on the opening of the Chelsea Flower Show
Toronto Wolfpack will market branded gels and creams that claim to relieve pain and stress
Canopy Growth’s $3.4bn deal with Acreage depends on federal legislation
Boehner-backed weed play Acreage agrees to $3.4bn Canopy takeover
The Mega Files: cannabis and cannabinoid investment opportunities
Steps to legalise marijuana have some investors hooked
Watchdogs are increasingly focused on the risks posed by ETFs. Plus: Bank of Japan’s ETF purchases raise concern; the fast rise and volatility of cannabis funds; bond funds head for $1tn; and dividend ETFs gain popularity
Campaigns to end prohibition should take account of psychiatric risks
An international study linking the use of strong cannabis to psychotic illnesses suc…
Hedge funds, investors and mutual funds are piling in after Canada allowed recreational usage
Opioid abuse is now taking its toll on drugmakers
Marijuana-infused beverages could become more socially acceptable than alcohol
Horizons Marijuana Life Sciences Index set to be country’s second most profitable ETF
Spending on the substance accounted for 0.5 per cent of household expenditure in 2018
Study shows device can detect ingredient in cannabis that gets people high
